comparemela.com

Frank Mottola News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Congress Asset Management Co MA Has $25 29 Million Stock Holdings in Supernus Pharmaceuticals, Inc (NASDAQ:SUPN)

Congress Asset Management Co. MA boosted its holdings in shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Free Report) by 19.1% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 917,164 shares of the specialty pharmaceutical company’s stock after buying an additional 147,105 shares during the […]

Supernus Pharmaceuticals, Inc (NASDAQ:SUPN) Shares Purchased by Campbell Newman Asset Management Inc

Campbell Newman Asset Management Inc. raised its holdings in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Free Report) by 63.7% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 42,355 shares of the specialty pharmaceutical company’s stock after purchasing an additional 16,476 shares during the quarter. Campbell […]

Legato Capital Management LLC Has $592,000 Holdings in Supernus Pharmaceuticals, Inc (NASDAQ:SUPN)

Legato Capital Management LLC decreased its holdings in shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Free Report) by 3.8% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 21,472 shares of the specialty pharmaceutical company’s stock after selling 837 shares during […]

Supernus Pharmaceuticals (NASDAQ:SUPN) Rating Increased to Buy at StockNews com

StockNews.com upgraded shares of Supernus Pharmaceuticals (NASDAQ:SUPN – Free Report) from a hold rating to a buy rating in a report released on Wednesday. Separately, Piper Sandler raised their price target on shares of Supernus Pharmaceuticals from $42.00 to $43.00 and gave the company an overweight rating in a research report on Thursday, November 9th. […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.